Study guide

4.1 Specimen Collection, Transport, Processing, and Microscopic Staining

Philippine Medical Technologists Licensure Examination MTLE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Clinical Chemistry: Laboratory Operations, Instrumentation, Reagents, Quality Assurance, and Safety

1.1 Specimen Collection, Preanalytical Variables, and Interferences 1.2 Clinical Chemistry Instrumentation, Photometry, and Automation 1.3 Quality Control, Westgard Rules, Calibration, and Laboratory Mathematics 1.4 Reagent Preparation, Laboratory Water, Glassware, Pipettes, and Centrifuges 1.5 Laboratory Safety: Chemical, Fire, Electrical, Biological, and Physical Hazards

2 Chapter 2: Clinical Chemistry: Carbohydrates, Lipids, Proteins, Non-Protein Nitrogen, and Liver Function

2.1 Glucose Homeostasis, Diagnostic Criteria for Diabetes Mellitus, and Glycemic Monitoring 2.2 Lipids, Lipoproteins, Apolipoproteins, and Coronary Heart Disease Risk Assessment 2.3 Serum Proteins, Albumin, Globulins, and Serum Protein Electrophoresis Patterns 2.4 Non-Protein Nitrogen Compounds: Urea, Creatinine, Uric Acid, and Renal Function 2.5 Liver Function Tests, Bilirubin Metabolism, and Jaundice

3 Chapter 3: Clinical Chemistry: Electrolytes, Blood Gases, Enzymology, Endocrinology, and Toxicology

3.1 Water Balance, Electrolytes, Osmolality, and Anion Gap Calculations 3.2 Blood Gas Analysis, Oxygenation, and Acid-Base Homeostasis 3.3 Clinical Enzymology: Enzyme Kinetics, Cardiac Biomarkers, and Hepatic and Pancreatic Enzymes 3.4 Endocrinology: Hormone Physiology and Endocrine Function Testing 3.5 Therapeutic Drug Monitoring and Clinical Toxicology

4 Chapter 4: Bacteriology: Specimen Management, Media, Staining, and Biosafety

4.1 Specimen Collection, Transport, Processing, and Microscopic Staining 4.2 Culture Media Classification, Quality Control, and Inoculation Techniques 4.3 Sterilization, Disinfection, Decontamination, and Biosafety Containment 4.4 Antimicrobial Susceptibility Testing Methods, Standardization, and Resistance Mechanisms

5 Chapter 5: Diagnostic Bacteriology: Major Pathogenic Bacteria

5.1 Medically Important Gram-Positive Cocci: Staphylococci, Streptococci, and Enterococci 5.2 Medically Important Gram-Negative Bacilli: Enterobacterales and Non-Fermenters 5.3 Fastidious, Microaerophilic, and Anaerobic Bacteria 5.4 Mycobacteria, Spirochetes, Atypical Bacteria, and Public Health Microbiology

6 Chapter 6: Medical Parasitology, Mycology, and Diagnostic Virology

6.1 Stool Examination Techniques and Intestinal Nematodes 6.2 Tissue Nematodes, Filarial Worms, Cestodes, and Trematodes 6.3 Medical Protozoology: Intestinal, Urogenital, and Blood/Tissue Protozoa 6.4 Medical Mycology: Yeasts, Dermatophytes, Dimorphic Fungi, and Opportunistic Molds 6.5 Clinical Virology: Viral Structure, Specimen Handling, and Diagnostic Methods

7 Chapter 7: Hematology: Specimen Collection, Routine Parameters, Instrumentation, and Manual Methods

7.1 Blood Specimen Collection, Anticoagulants, Preanalytical Variables, and Specimen Quality 7.2 Automated Cell Counting Principles, Complete Blood Count Parameters, and Erythrocyte Indices 7.3 Reticulocyte Evaluation, Supravital Staining, and Erythrocyte Sedimentation Rate 7.4 Manual Cell Counts, Manual Hemoglobin Methods, and Hematology Quality Control

8 Chapter 8: Hematology: Blood Cell Morphology, Bone Marrow, and Hematologic Disorders

8.1 Normal Erythropoiesis and Erythrocyte Morphologic Abnormalities 8.2 Anemias: Classification, Iron Deficiency, Megaloblastic, Hemolytic, and Hemoglobinopathies 8.3 Normal Leukopoiesis, Leukocyte Differential, and Non-Malignant White Cell Alterations 8.4 Hematologic Malignancies: Acute and Chronic Leukemias, Myeloproliferative and Lymphoproliferative Disorders 8.5 Peripheral Blood Smear Preparation and Staining, Bone Marrow Examination, and Cytochemistry

9 Chapter 9: Hemostasis: Coagulation and Platelet Function Testing and Hemostatic Disorders

9.1 Mechanisms of Primary and Secondary Hemostasis, Fibrinolysis, and Natural Inhibitors 9.2 Coagulation Laboratory Testing: PT/INR, aPTT, Fibrinogen, Thrombin Time, and Mixing Studies 9.3 Hemostatic and Thrombotic Disorders: Hemophilias, von Willebrand Disease, DIC, and Thrombophilias 9.4 Bleeding Time, Clotting Time, Platelet Function, and Special Hematology Tests

10 Chapter 10: Immunohematology: Blood Group Systems and Antiglobulin Testing

10.1 The ABO Blood Group System, Genetics, Subgroups, and Forward/Reverse Typing Discrepancies 10.2 The Rh Blood Group System, Weak D Testing, and Other Major Blood Group Systems 10.3 Antiglobulin Testing, Elution, Adsorption, and Special Antibody Procedures

11 Chapter 11: Blood Banking: Donor Operations, Component Therapy, and Adverse Reactions

11.1 Donor Selection, Physical Examination, Screening, and Mandatory Infectious Marker Testing 11.2 Blood Component Preparation, Storage, Expiration, and Indications for Transfusion 11.3 Pre-Transfusion Compatibility Testing and Transfusion Reactions 11.4 Hemolytic Disease of the Fetus and Newborn (HDFN) and Rh Immune Globulin

12 Chapter 12: Clinical Serology and Immunology

12.1 Principles of Immunology: Antigens, Antibodies, Complement, and Immune Responses 12.2 Serologic Testing Methodologies: Agglutination, Precipitation, Flocculation, and Labeled Immunoassays 12.3 Infectious Disease Serology: Syphilis, Viral Hepatitis Markers, HIV, Dengue, and Febrile Agglutinins 12.4 Autoimmune Serology, Hypersensitivity, Immunodeficiencies, and Histocompatibility (HLA)

13 Chapter 13: Clinical Microscopy: Urinalysis and Renal Pathology

13.1 Renal Physiology, Urine Formation, and Physical Examination of Urine 13.2 Chemical Examination of Urine: Reagent Strip Principles, Interferences, and Confirmatory Tests 13.3 Microscopic Examination of Urine Sediment: Cells, Casts, Crystals, and Contaminants 13.4 Renal Calculi, Glomerular/Tubular/Interstitial Renal Diseases, and Urinalysis Quality Control

14 Chapter 14: Clinical Microscopy: Body Fluids, Fecal Analysis, and Gastric, Duodenal, and Respiratory Specimens

14.1 Cerebrospinal Fluid Analysis: Collection, Cell Counts, Chemistry, and Microbiology 14.2 Serous Fluids (Pleural, Pericardial, Peritoneal: Transudates vs Exudates) and Synovial Fluid Analysis 14.3 Seminal Fluid and Amniotic Fluid Analysis 14.4 Fecal Analysis: Macroscopic, Microscopic, and Chemical Examination of Stool 14.5 Gastric Fluid, Duodenal Contents, Sputum, and Bronchoalveolar Specimens

15 Chapter 15: Histopathologic Techniques and Cytotechnology

15.1 Tissue Preservation, Fixation, Decalcification, and Processing Steps 15.2 Microtomy, Sectioning Artifacts, Hematoxylin and Eosin Staining, and Special Stains 15.3 Cytotechnology: Specimen Collection, Fixation, Papanicolaou Staining, and the Bethesda System 15.4 Special Procedures: Frozen Sections, Special Embedding, Immunohistochemistry, Electron Microscopy, Autopsy, Museum Techniques, and Laboratory Records

16 Chapter 16: Medical Technology Laws, Related Laws, and Ethics

16.1 Republic Act No. 5527 (The Philippine Medical Technology Act of 1969) and Key Amendments 16.2 Related Philippine Healthcare Laws, Code of Ethics, and Bioethics

4.1 Specimen Collection, Transport, Processing, and Microscopic Staining

Key Takeaways Explain This Topic AI

Diagnostic bacteriology specimens must be collected during the acute phase of infection prior to antimicrobial administration, prioritizing aspirates and tissue biopsies over swabs to optimize pathogen recovery.

Under Murray-Washington and Bartlett criteria, expectorated sputum with > 10 >10 > 10 squamous epithelial cells per low-power field ( 100 × 100\times 100 × ) indicates oropharyngeal salivary contamination and must be rejected, whereas > 25 >25 > 25 PMNs per LPF confirm authentic lower respiratory origin.

The Gram stain differentiates bacteria based on cell wall architecture: acetone-alcohol decolorizer dissolves the lipid-rich outer membrane of Gram-negative bacteria, leaching the crystal violet-iodine complex, while dehydrating the thick peptidoglycan mesh of Gram-positive cells to trap the primary stain.

Acid-fastness relies on cell wall mycolic acids ( 60 to 90 60\text{ to }90 60 to 90 carbons) cross-linked to arabinogalactan, forming a waxy hydrophobic barrier impervious to conventional aqueous dyes and resistant to decolorization by 3 % 3\% 3% acid-alcohol.

Last updated: October 2026

Specimen Collection, Transport, Processing, and Microscopic Staining

In diagnostic medical bacteriology, the analytical validity of culture, identification, and antimicrobial susceptibility testing is governed by the quality of the specimen submitted. A poorly collected or improperly transported sample produces misleading culture results, promotes antimicrobial misuse, and obscures the true etiology of infectious disease. For medical technologists preparing for the Philippine Medical Technologists Licensure Examination (MTLE) and international certifications (ASCPi), mastering preanalytical collection protocols, transport systems, specimen rejection criteria, and microscopic staining chemistry is fundamental to clinical laboratory practice.

1. Principles of Specimen Collection and Preanalytical Variables

Optimal recovery of pathogenic microorganisms requires adherence to core microbiological collection guidelines:

Timing Prior to Antimicrobial Therapy : Diagnostic specimens must be collected during the acute phase of illness and prior to initiating empiric antimicrobial therapy . Residual antibiotics in patient secretions suppress in vitro microbial growth, yielding false-negative cultures.

Anatomical Site Selection and Normal Flora Avoidance : Specimens must represent the active site of infection while avoiding surface colonization by indigenous normal flora. Decontaminating adjacent skin and mucosal margins (e.g., chlorhexidine or povidone-iodine antisepsis before venipuncture) is mandatory.

Specimens of Choice (Aspirates/Tissues vs. Swabs) : Needle aspirates of purulent fluids and surgically excised tissue biopsies represent the gold standard. Swabs are distinctly inferior because they collect low sample volumes (approx. 0.05 mL 0.05\text{ mL} 0.05 mL ), promote rapid desiccation, trap microbes within synthetic fibers, and are easily contaminated by surface colonizers. Furthermore, standard cotton-tipped swabs contain toxic unsaturated fatty acids that inhibit fastidious species such as Neisseria gonorrhoeae and Bordetella pertussis ; calcium alginate or Dacron (polyester) swabs must be utilized when swabs cannot be avoided.

Blood Culture Collection Protocols

Bloodstream infections carry severe mortality and demand rigorous collection standards:

Blood Volume per Bottle : The single most critical variable determining pathogen detection is the volume of blood cultured. For adult patients, 8 to 10 mL 8\text{ to }10\text{ mL} 8 to 10 mL per bottle ( 16 to 20 mL 16\text{ to }20\text{ mL} 16 to 20 mL per set) is required. Inoculating inadequate blood volumes yields false-negative results due to low-level bacteremia ( < 1 to 10 CFU/mL <1\text{ to }10\text{ CFU/mL} < 1 to 10 CFU/mL ). For pediatric patients, blood volumes are adjusted to total patient body weight ( 1 to 3 mL 1\text{ to }3\text{ mL} 1 to 3 mL per bottle in pediatric blood culture bottles).

Number of Sets and Phlebotomy Sites : A standard septic workup requires 2 to 3 blood culture sets (each consisting of one aerobic and one anaerobic bottle) collected from separate venipuncture sites within a 24-hour period. Collecting multiple sets achieves > 95 % >95\% > 95% cumulative diagnostic sensitivity and distinguishes true pathogens from skin contamination.

Differentiating Contaminants from True Bacteremia : Common skin commensals—such as Coagulase-Negative Staphylococci ( Staphylococcus epidermidis ), Cutibacterium acnes , Corynebacterium species (diphtheroids), and Bacillus species—isolated from only a single bottle among multiple sets typically represent venipuncture contamination. Conversely, the isolation of skin flora from ≥ 2 \ge 2 ≥ 2 independent venipuncture sets, or isolation of virulent pathogens ( Staphylococcus aureus , Streptococcus pneumoniae , Escherichia coli , Pseudomonas aeruginosa , Candida albicans ) in any bottle, indicates authentic bloodstream infection.

Anticoagulant Formulation : The anticoagulant of choice for blood culture bottles is Sodium Polyanethol Sulfonate (SPS) at concentrations of 0.025 % to 0.05 % 0.025\%\text{ to }0.05\% 0.025% to 0.05% . SPS is a polyanionic anticoagulant that also inactivates human serum complement, neutralizing lysozyme activity, and inhibiting phagocytosis as well as polycationic antibiotics (polymyxins, aminoglycosides). However, SPS can inhibit certain fastidious bacteria: Neisseria gonorrhoeae , Neisseria meningitidis , Gardnerella vaginalis , Streptobacillus moniliformis , and Peptostreptococcus anaerobius . Adding 1.2 % 1.2\% 1.2% gelatin neutralizes the inhibitory effect of SPS without impairing anticoagulation.

2. Lower Respiratory Specimen Quality Assessment

Expectorated sputum passes through the oropharynx, where it easily acquires saliva and oral squamous commensals ( Streptococcus mitis , Neisseria spp., Rothia spp.). Culturing saliva generates misleading bacterial overgrowth. Therefore, laboratories screen sputum smears microscopically under low-power magnification ( 100 × 100\times 100 × ) prior to culture inoculation.

Murray-Washington and Bartlett Cytological Criteria

Squamous Epithelial Cells (SECs) : SECs originate from the superficial stratified squamous epithelium of the oral cavity and oropharynx. A high SEC count indicates salivary contamination. Specimens displaying > 10 SECs per low-power field (LPF) >10\text{ SECs per low-power field (LPF)} > 10 SECs per low-power field (LPF) are rejected as unsatisfactory for bacterial culture.

Polymorphonuclear Leukocytes (PMNs / Neutrophils) : Neutrophils signify an active lower respiratory inflammatory response. An acceptable, purulent sputum specimen contains > 25 PMNs per LPF >25\text{ PMNs per LPF} > 25 PMNs per LPF .

Classification Scheme Microscopic Evaluation Criteria (at 100 × 100\times 100 × magnification) Clinical Laboratory Action

Murray-Washington Group 1 > 25 SECs >25\text{ SECs} > 25 SECs and < 10 PMNs <10\text{ PMNs} < 10 PMNs per LPF Reject specimen (Gross saliva; request re-collection)

Murray-Washington Group 2 > 25 SECs >25\text{ SECs} > 25 SECs and 10 – 25 PMNs 10\text{--}25\text{ PMNs} 10 – 25 PMNs per LPF Reject specimen (Saliva; request re-collection)

Murray-Washington Group 3 > 25 SECs >25\text{ SECs} > 25 SECs and > 25 PMNs >25\text{ PMNs} > 25 PMNs per LPF Reject specimen (Heavy oral contamination)

Murray-Washington Group 4 10 – 25 SECs 10\text{--}25\text{ SECs} 10 – 25 SECs and > 25 PMNs >25\text{ PMNs} > 25 PMNs per LPF Acceptable in the original scheme; many laboratories apply the stricter < 10 SEC <10\text{ SEC} < 10 SEC rule and reject

Murray-Washington Group 5 < 10 SECs <10\text{ SECs} < 10 SECs and > 25 PMNs >25\text{ PMNs} > 25 PMNs per LPF Accept specimen (Purulent lower respiratory tract sputum)

Few cells of either type < 10 SECs <10\text{ SECs} < 10 SECs and few PMNs per LPF Interpret with the clinical picture (for example, a neutropenic patient cannot mount a PMN response)

Bartlett's Scoring Index Neutrophils: 10 – 25 /LPF = + 1 10\text{--}25\text{/LPF} = +1 10 – 25 /LPF = + 1 ; > 25 /LPF = + 2 >25\text{/LPF} = +2 > 25 /LPF = + 2 ; Mucus present = + 1 = +1 = + 1 ; SECs: 10 – 25 /LPF = − 1 10\text{--}25\text{/LPF} = -1 10 – 25 /LPF = − 1 ; > 25 /LPF = − 2 >25\text{/LPF} = -2 > 25 /LPF = − 2 Score ≤ 0 \le 0 ≤ 0 : Reject (Contaminated); Score ≥ + 1 \ge +1 ≥ + 1 : Accept and process for culture

Exam Key Point : Expectorated sputum is strictly unacceptable for anaerobic culture because normal oral flora contains up to 10 8 to 10 9 10^8\text{ to }10^9 1 0 8 to 1 0 9 anaerobes per milliliter of saliva. Anaerobic pulmonary cultures require transtracheal aspirates, protected specimen brush (PSB), bronchoalveolar lavage (BAL), or percutaneous lung biopsy.

3. Specimen Transport Media and Environmental Stabilization

Transport media maintain microbial viability while preventing bacterial multiplication or overgrowth of commensals during the transit interval between phlebotomy and laboratory plating. They consist of non-nutritive buffered salt solutions lacking carbon, nitrogen, and organic growth factors:

Stuart's and Amies Transport Media : Semisolid, buffered transport media with sodium thioglycollate as a reducing agent to minimize oxidative stress. Amies medium with charcoal contains finely divided charcoal to adsorb toxic metabolic free fatty acids and trace toxic heavy metals that kill fastidious organisms such as Neisseria gonorrhoeae and Bordetella pertussis .

Cary-Blair Transport Medium : Formulated for stool specimens and rectal swabs suspected of carrying enteric pathogens ( Salmonella , Shigella , Campylobacter jejuni , and Vibrio cholerae ). Cary-Blair maintains an elevated alkaline pH of 8.4 \text{pH of } 8.4 pH of 8.4 , low oxidation-reduction potential, and minimal nutrient density, preserving delicate Vibrio species that lyse rapidly in acidic stool.

Anaerobic Transport Systems (PRAS Vials) : Pre-reduced anaerobically sterilized (PRAS) vials flushed with oxygen-free nitrogen and carbon dioxide gas. Formulated with reducing agents (sodium thioglycollate, L-cysteine) and an oxidation-reduction indicator, such as resazurin (pink when oxidized, colorless when reduced) or methylene blue (blue when oxidized, white when reduced).

Viral Transport Medium (VTM) : Buffered salt solution enriched with a protein stabilizer (bovine serum albumin or gelatin) and an antimicrobial cocktail (vancomycin, gentamicin, amphotericin B) to eliminate bacterial and fungal overgrowth. Specimens in VTM are transported on wet ice at 2 to 8 ∘ C 2\text{ to }8^\circ\text{C} 2 to 8 ∘ C for up to 72 hours. For prolonged storage, samples must be frozen at − 70 ∘ C -70^\circ\text{C} − 7 0 ∘ C (never stored at − 20 ∘ C -20^\circ\text{C} − 2 0 ∘ C because slow freezing generates ice crystals that disrupt viral envelopes).

4. Bacterial Staining Principles, Chemistry, and Troubleshooting

Microscopic examination of stained smears provides immediate preliminary taxonomic clues guiding empiric antimicrobial selection.

The Gram Stain (Differential Staining Mechanism)

Introduced by Christian Gram in 1884, the Gram stain separates bacteria into two major structural divisions based on the biochemical architecture of their cell envelopes: ┌──────────────────────────────────────────────┐

  • │ Gram Stain Reaction Cycle │
  • └──────────────────────┬───────────────────────┘
  • │
  • ┌───────────────────────────────────────┼──────────────────────────────────────┐
  • ▼ ▼ ▼
  • ┌──────────────┐ ┌──────────────┐ ┌──────────────┐
  • │Crystal Violet│ │ Gram's Iodine│ │Acetone-Alcoh.│
  • │Primary: 1 min│ │Mordant: 1 min│ │Decolor: 3-5 s│
  • └──────┬───────┘ └──────┬───────┘ └──────┬───────┘
  • │ │ │

Stains all bacterial Forms large, insoluble Critical differential step:

  • cytoplasm deep purple CV-I complexes inside • G+ thick peptidoglycan
  • (basic triphenylmethane peptidoglycan matrix dehydrates; pores shrink;
  • cation binds negative CV-I trapped (purple)
  • nucleic acids) • G- lipid outer membrane
  • dissolves; thin peptidoglycan
  • leaches CV-I (colorless)
  • │
  • ▼
  • ┌──────────────┐
  • │ Safranin O │
  • │Counter: 30-60│
  • └──────────────┘
  • Stains decolorized G-
  • bacteria red / pink

Primary Stain (Crystal Violet, 1 minute) : Crystal violet dissociates into C V + CV^+ C V + and C l − Cl^- C l − ions in aqueous solution. The basic triphenylmethane dye penetrates the cell wall and binds electrostatically to negatively charged phosphate groups in bacterial RNA, DNA, and teichoic acids, staining all bacterial cells purple.

Mordant (Gram's Iodine, 1 minute) : Iodine ( I − I^- I − or I 3 − I_3^- I 3 − ​ ) acts as a trapping agent or chemical mordant, interacting with intracellular crystal violet to form large, water-insoluble crystal violet-iodine (CV-I) complexes ( [ C V + I 3 − ] [CV^+I_3^-] [ C V + I 3 − ​ ] ).

Decolorizer (95% Ethanol or 1:1 Acetone-Alcohol, 3 to 5 seconds) : This is the most critical and operator-sensitive step :

Gram-Positive Envelope : Consists of a thick, multilayered cross-linked peptidoglycan (murein) meshwork ( 40 – 80 nm 40\text{--}80\text{ nm} 40 – 80 nm ) rich in wall teichoic and lipoteichoic acids. The alcohol solvent dehydrates the peptidoglycan, collapsing its intercellular pores and physically trapping the bulky CV-I precipitate within the cross-linked matrix. Gram-positive cells retain the primary dye and remain purple .

Gram-Negative Envelope : Consists of a thin monolayer of peptidoglycan ( 2 – 7 nm 2\text{--}7\text{ nm} 2 – 7 nm ) surrounded by an asymmetric outer membrane containing lipopolysaccharide (LPS: Lipid A, core polysaccharide, O-antigen) and phospholipids. The acetone-alcohol solvent dissolves the lipid-rich outer membrane and increases permeability across the thin peptidoglycan layer, allowing rapid extraction and leaching of the CV-I complexes. Gram-negative cells become completely colorless .

Counterstain (Safranin O, 30 to 60 seconds) : Safranin O (basic red dye) imparts a pink-to-red hue to the decolorized Gram-negative bacteria while having no visual impact on the dark purple Gram-positive bacteria. For fastidious, faintly staining Gram-negative species ( Legionella pneumophila , Campylobacter jejuni , Bartonella , Brucella ), 0.1 % to 0.2 % 0.1\%\text{ to }0.2\% 0.1% to 0.2% basic fuchsin or carbolfuchsin should be substituted for safranin to provide superior contrast.

Gram Stain Technical Troubleshooting

Over-decolorization : Prolonged exposure to acetone-alcohol extracts CV-I from Gram-positive cells, causing them to appear falsely Gram-negative (pink) . White blood cells and host tissue cells serve as internal quality control: they must always decolorize cleanly and stain pale pink. If host leukocytes stain purple, the slide is under-decolorized.

Under-decolorization : Insufficient decolorization fails to extract CV-I from Gram-negative bacteria, leaving them falsely Gram-positive (purple) .

Culture Age and Autolysis : Cultures older than 24 hours lose peptidoglycan structural integrity due to autolytic enzyme release, resulting in Gram-variable or false Gram-negative staining. This is particularly prevalent in Streptococcus pneumoniae and Bacillus species.

Excessive Heat-Fixation : Overheating the glass slide alters cell wall architecture, rendering Gram-positive organisms susceptible to premature decolorization.

Crystal Violet Precipitate : Unfiltered or evaporated crystal violet generates needle-shaped or amorphous dark purple crystalline artifacts that mimic Gram-positive cocci ( Staphylococcus ).

Acid-Fast Stains (Mycobacteriology)

Biochemical Basis of Acid-Fastness : The cell wall of Mycobacterium species ( M. tuberculosis , M. leprae , M. avium complex) is composed of up to 60 % 60\% 60% lipid by dry weight . The outer envelope contains high-molecular-weight branched β \beta β -hydroxy fatty acids called mycolic acids ( 60 to 90 60\text{ to }90 60 to 90 carbon atoms), covalently esterified to arabinogalactan, which in turn is anchored to peptidoglycan. This lipid-rich matrix also contains cord factor (trehalose 6,6'-dimycolate) and lipoarabinomannan (LAM). This forms a dense, waxy, hydrophobic barrier that repels water-soluble basic dyes and resists destaining by strong mineral acid decolorizers.

Ziehl-Neelsen (ZN) "Hot" Method : Uses carbolfuchsin (basic fuchsin dissolved in 5 % 5\% 5% aqueous phenol). The slide is heated with a flame or steam for 5 minutes; heat and phenol melt the waxy mycolic acids, driving carbolfuchsin into the cytoplasm. Decolorization is performed using 3 % 3\% 3% Hydrochloric Acid ( H C l HCl H Cl ) in 95 % 95\% 95% Ethanol (acid-alcohol). Non-acid-fast bacteria and host cells decolorize completely. Counterstaining with methylene blue (or brilliant green) stains background cellular elements blue, while Acid-Fast Bacilli (AFB) retain carbolfuchsin, appearing as slender, beaded red/magenta rods .

Kinyoun "Cold" Method : Uses a modified carbolfuchsin containing an elevated concentration of basic fuchsin ( 4 % 4\% 4% ) and phenol ( 8 % 8\% 8% ) combined with a detergent/wetting agent (tergitol). The high lipid solubility of this formulation penetrates the waxy cell wall at room temperature without requiring heat. It uses identical 3 % 3\% 3% acid-alcohol decolorizer and methylene blue counterstain.

Modified Kinyoun (Partial / Weak Acid-Fast Stain) : Certain actinomycetes have shorter mycolic acid chains ( 30 to 50 30\text{ to }50 30 to 50 carbons) and decolorize when exposed to standard 3 % H C l 3\%\text{ }HCl 3% H Cl acid-alcohol. To detect these partially acid-fast organisms—specifically Nocardia species , Rhodococcus , Gordonia , Tsukamurella , and coccidian parasites (oocysts of Cryptosporidium , Cystoisospora , and Cyclospora )—a weak decolorizer of 0.5 % to 1.0 % Sulfuric Acid ( H 2 S O 4 ) 0.5\%\text{ to }1.0\%\text{ Sulfuric Acid } (H_2SO_4) 0.5% to 1.0% Sulfuric Acid ( H 2 ​ S O 4 ​ ) is utilized. Nocardia stains branching, beaded pink-red filaments, whereas non-acid-fast Actinomyces species decolorize and stain blue.

Fluorochrome Stain (Auramine-Rhodamine) : Auramine O and Rhodamine B fluorescent dyes selectively bind to mycolic acids. After staining, smears are decolorized with 0.5 % 0.5\% 0.5% acid-alcohol and quenched with 0.5 % 0.5\% 0.5% potassium permanganate ( K M n O 4 KMnO_4 K M n O 4 ​ ) to eliminate non-specific background fluorescence. Under UV or blue LED fluorescence microscopy, acid-fast bacilli fluoresce bright yellow-gold to orange against a dark background. The fluorochrome technique permits rapid screening under lower magnifications ( 250 × or 450 × 250\times\text{ or }450\times 250 × or 450 × ), allowing technologists to review significantly more surface area in less time.

Special Microscopic Staining Techniques

Staining Method Target Structure Reagents / Mechanism Microscopic Appearance / Clinical Application

India Ink / Nigrosin Capsule (Negative Staining) Colloidal carbon particles cannot penetrate the polysaccharide capsule Unstained, luminous clear halo surrounding yeast cells against a dark carbon background; diagnostic for Cryptococcus neoformans in CSF

Anthony's Capsule Stain Bacterial Capsule Primary stain: Crystal violet without heat-fixing; Decolorizer/Counterstain: 20 % 20\% 20% Copper Sulfate ( C u S O 4 CuSO_4 C u S O 4 ​ ) Bacterial body stains dark violet; capsule appears as a faint blue/clear halo surrounding the cell

Schaeffer-Fulton Bacterial Endospores Primary: 5 % 5\% 5% Malachite Green with steam heat; Rinse: Water; Counterstain: Safranin O Highly resistant keratin-like spore coats force malachite green retention: green endospores within pink/red vegetative bacilli ( Bacillus and Clostridium )

Leifson / Fontana Flagella Precipitating agent: Tannic acid and rosaniline dye / ammoniacal silver nitrate Submicroscopic flagella ( 12 – 20 nm 12\text{--}20\text{ nm} 12 – 20 nm ) are coated with colloidal precipitates, thickening them beyond optical resolution limits ( > 200 nm >200\text{ nm} > 200 nm ) to assess polar, lophotrichous, or peritrichous motility arrays